Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HMG-CoA Reductase Inhibitor [EPC]: Side Effects & Safety Data for 7 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HMG-CoA Reductase Inhibitor [EPC] includes 7 drugs with a combined 156,760 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

7
Drugs in Class
156,760
Combined Reports

All HMG-CoA Reductase Inhibitor [EPC] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
ATORVASTATIN Atorvastatin calcium 79,519 4,992 24,078 6.3%
ROSUVASTATIN Rosuvastatin Calcium 36,332 1,536 11,195 4.2%
SIMVASTATIN Simvastatin 27,079 2,792 8,824 10.3%
PRAVASTATIN Pravastatin Sodium 8,284 923 2,338 11.1%
PITAVASTATIN Pitavastatin 2,344 346 351 14.8%
FLUVASTATIN FLUVASTATIN SODIUM ER 1,815 323 515 17.8%
LOVASTATIN Lovastatin 1,387 204 287 14.7%

Common Side Effects in HMG-CoA Reductase Inhibitor [EPC] Drugs

Side EffectReportsDeaths
Myalgia 17,751 1,056
Fatigue 8,761 1,039
Dyspnoea 8,537 1,350
Type 2 diabetes mellitus 8,514 104
Arthralgia 8,218 1,062
Drug ineffective 8,043 227
Drug hypersensitivity 7,848 176
Rhabdomyolysis 7,442 655
Pain 7,106 73
Nausea 7,005 1,254
View detailed side effects for this class → Compare drugs in this class →